Lexaria Is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace
Utilizing DehydraTECHTM, their proprietary drug delivery technology, they are showing that its benefits can enrich more than just CBD medical applications.
- Utilizing DehydraTECHTM, their proprietary drug delivery technology, they are showing that its benefits can enrich more than just CBD medical applications.
- Extensive testing has shown that it reduces the time for CBD to enter the bloodstream, increases absorption rate, and improves taste and smell.
- This revolutionary technology is currently being tested in a number of medical applications, including anti-hypertensive drugs and Covid-19 vaccine and treatment options.
- Lexaria is already generating profits on CBD-infused beverages and edibles, a market that Statista estimated will be worth $2.65 billion by 2025.